Outcome of chronic hemodialysis patients in one poorest coun-try in the world: the Zinder experience.

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

Abstract Title *

Outcome of chronic hemodialysis patients in one poorest coun-try in the world: the Zinder experience.

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Hassane MOUSSA DIONGOLE hassane.moussadiongole@uas.edu.ne Faculty of Health Sciences/ Andre Salifou University Nephrology Zinder Niger *

Co-author 2

Djibril AHMED ALATININE alatininedjibrilahmed@gmail.com National Hospital Nephrology Zinder Niger -

Co-author 3

Maman Bachir GONI dit ALASSAN gonialassanb@gmail.com Faculty of Health Sciences/ Andre Salifou University Public Health and Epidemiology Zinder Niger -

Co-author 4

Zeinabou Maiga MOUSSA TONDI zeinab_maiga@yahoo.fr Faculty of Health Sciences/ Abdou Moumouni University Nephrology Niamey Niger -

Co-author 5

Assoumane ZABEIROU HANAHI hanahizabeirouassoumana@gmail.com National Hospital Nephrology Zinder Niger -

Co-author 6

Co-author 7

Co-author 8

Co-author 9

Co-author 10

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15

Introduction

Chronic hemodialysis therapy is a well-recognized supportive therapy for patients with end-stage kidney disease. However, this therapy is poorly implemented in low-income countries due to its high cost. We herein report a single-center experience in one of the poorest countries in the world, i.e., Niger.

Methods

This is a cross-sectional study that included all incident patients presenting with serum creatinine greater than 1000 µmol/L (January 2018 to December 2022). They all agreed to be treated with self-funded chronic hemodialysis. Survival was evaluated as of December 2024

Results

A total of 544 patients initiated hemodialysis therapy. Among them, 423 (77.8%) underwent hemodialysis for less than 3 months: 240 (57%) died; 57 (13.5%) recovered renal function; and the others were lost to follow-up or decided to discontinue hemodialysis. Only 121 patients (22.2%) were able to embark on a chronic hemodialysis therapy program; most of them were males (sex ratio of 2.7). Their mean age was 48 years. Most (62%) were from rural areas. Additionally, 66% had low economic incomes, and 52% lived very far from our dialysis facility. Vascular access was predominantly a central venous catheter (75%). Non-adherence to hemodialysis was observed in 76% of patients. Dropouts and lost-to-follow-up occurred in 15.7% and 29% of cases, respectively. At the end of follow-up, only 10 patients (8.3%) were still alive.

Conclusion

These results question the utility of chronic hemodialysis in very low-income countries due to its high cost and significant mortality. Where possible, kidney transplantation abroad should be offered as supportive therapy as soon as it is known that there will be no renal recovery.

Kewords